发明名称 PROCEDURE FOR THE INVERSION OF THE STEREOCHEMISTRY AT C13 OF AVERMECTIN AGLYCONE COMPOUNDS
摘要 The natural stereochemistry at the 13-position of avermectin aglycones, normally alpha -oriented or below the plane of the molecule, is inverted or epimerized into the beta -position. The procedure starts with the avermectin aglycone compounds where the 13 alpha -hydroxy group is substituted with a leaving group. Treatment of the substituted compound with tetra alkyl ammonium nitrate displaces the leaving group, substitutes a nitrate ester or a nitrooxy group, for the hydroxy and inverts the 13-stereochemistry to beta . Reduction of the nitrooxy group returns the 13-hydroxy group and retains the 13- beta configuration. The intermediate 13-nitrooxy compounds are themselves potent anti-parasitic agents.
申请公布号 ZA9203421(B) 申请公布日期 1992.12.30
申请号 ZA19920003421 申请日期 1992.05.12
申请人 MERCK & CO. INC. 发明人 TODD K. JONES;HELMUT MROZIK
分类号 A01N43/90;A61K31/365;A61P33/00;A61P33/10;C07D493/22;C07H19/01 主分类号 A01N43/90
代理机构 代理人
主权项
地址